Trial
NCT01410708
TORI 104 Pre-Surgical Dasatinib
Phase IIWITHDRAWNSAFETYConfidence: HIGH
Sponsor
AHS Cancer Control Alberta
Collaborators
—
Condition
Breast Cancer
Intervention
Dasatinib
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-02-17